Status: Recruiting
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
This is a non-interventional, multi-country, multi-centre, multicohort, primary data collection study, designed to assess patients' reported satisfaction with Atezolizumab Subcutenous (SC) treatment and Health-related Quality of Life (HRQoL), as well as the effectiveness and safety of Atezolizumab SC in participants treated for selected approved indications in routine clinical practice.
Participants needed: 700
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Hoffmann-La RocheUpdated: Aug 17, 2026Locations: 91
Eligibility criteria
Early stage NSCLC following complete resection and platinum-based chemotherapy w... [+4]
Not receiving treatment with Atezolizumab according to standard of care and in l... [+3]